Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
45 hedge funds and large institutions have $5.19M invested in Nymox Pharmaceutical Corp in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 3 closing their positions.
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
36% more capital invested
Capital invested by funds: $3.8M → $5.19M (+$1.39M)
18% more funds holding
Funds holding: 38 → 45 (+7)
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
33% less call options, than puts
Call options by funds: $27K | Put options by funds: $40K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
ExodusPoint Capital Management
New York
|
+$194K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$178K |
| 3 |
6CM
683 Capital Management
New York
|
+$169K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$132K |
| 5 |
PFGIA
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
|
+$71K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$219K |
| 2 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$98.7K |
| 3 |
LP
LMR Partners
London,
United Kingdom
|
-$64K |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
-$39.9K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$38.4K |
NYMX Hedge Fund Activity: Q4 2019 in Review
45 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q4 2019, worth a combined $5.19M — up 36% from $3.8M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new NYMX positions and 3 closed out — a net gain of 7 holders — while 9 added to existing stakes and 11 trimmed.
The largest buyer was ExodusPoint Capital Management, opening a new position worth an estimated $194K. The largest seller was Millennium Management, cutting an estimated $219K.
- 45 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q4 2019, up from 38 in Q3 2019.
- Funds reported $5.19M of Nymox Pharmaceutical Corp stock for Q4 2019, up 36% quarter-over-quarter.
- 10 funds opened new Nymox Pharmaceutical Corp positions in Q4 2019 and 3 closed out, a net change of +7 holders.
- The largest Nymox Pharmaceutical Corp buyer in Q4 2019 was ExodusPoint Capital Management, an estimated $194K added.
- The largest Nymox Pharmaceutical Corp seller in Q4 2019 was Millennium Management, an estimated $219K sold.
Based on aggregated 13F filings for Q4 2019.